Pharmacokinetics of Furosemide in Patients with Congestive Heart Failure
- 1 January 1979
- journal article
- research article
- Published by S. Karger AG in Pharmacology
- Vol. 19 (3), 121-131
- https://doi.org/10.1159/000137299
Abstract
A pharmacokinetic study of furosomide was undertaken in 7 patients with severe congestive heart failure. The extent of oral availability, determined by the ratio of areas under the oral to i.v. plasma concentration-time curve, averaged 61%, but varied widely from patient to patient, from 34-80%. Absorption of the drug was often delayed, with a lag time before appearance in the plasma averaging 28 .+-. (SD) 15 min. The volume of distribution of furosemide (averaging 114 ml/kg) was not diminished in the presence of congestive failure and drug clearance and elimination half-lives are similar to values reported in normal subjects. Urinary flow rates 1-2 h after dosing were significantly less after oral than i.v. dosing, but flow rates over 4, 8 or 24 h after dosing were similar for both routes of administration.This publication has 7 references indexed in Scilit:
- Pharmacokinetics/pharmacodynamics of furosemide in man: A reviewJournal of Pharmacokinetics and Biopharmaceutics, 1979
- Plasma binding and disposition of furosemide in the nephrotic syndrome and in uremiaClinical Pharmacology & Therapeutics, 1978
- Furosemide kinetics in renal failureClinical Pharmacology & Therapeutics, 1978
- Distribution, elimination and effect of furosemide in normal subjects and in patients with heart failureEuropean Journal of Clinical Pharmacology, 1977
- Absorption, Distribution, Metabolism, and Excretion of Furosemide in Dogs and Monkeys I: Analytical Methodology, Metabolism, and Urinary ExcretionJournal of Pharmaceutical Sciences, 1976
- Lidocaine Pharmacokinetics in Advanced Heart Failure, Liver Disease, and Renal Failure in HumansAnnals of Internal Medicine, 1973
- New Method for Calculating the Intrinsic Absorption Rate of DrugsJournal of Pharmaceutical Sciences, 1968